课题基金 / 基金详情

Establishment of molecular targeting therapy for duonic heart failure bystabilizmgryanodine receptor

Establishment of molecular targeting therapy for duonic heart failure bystabilizmgryanodine receptor
稳定麦草碱受体治疗双元心力衰竭分子靶向治疗的建立
批准号:
18390234
负责人:
YANO Masafumi
金额:
$9.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YANO Masafumi的其他基金

相关文献

中文摘要
翻译
发现肌浆网(SR)的兰尼碱受体(RyR 2)内的两个结构域{N末端(0-600)和中央(2000-2500)结构域}相互作用,作为通道门控的调节开关。我们以前报道过K201(JTV 519)通过纠正衰竭心脏中两个结构域之间的缺陷性结构域间相互作用来抑制Ca^2+渗漏。在此,我们鉴定了K201的结合结构域,并鉴定了这个新结构域对RyR 2通道门控的作用。2270在1-2750区域。通过进一步分析片段1741 -2270,发现201与其亚片段2114 -2149特异性结合。使用与该亚片段匹配的肽(DP 2114 -2149)作为载体,用甲基香豆素乙酸酯(MCA)特异性标记RyR 2。此外,在几个重组RyR 2片段中,仅片段2234-2750被特异性MCA标记;这表明K201结合结构域2114 -2149与结构域2234-2750结合。将DP 2114 -2149添加到MCA标记的SR中干扰了结构域2114 -2149和结构域2234 -2750之间的相互作用,导致结构域解链,如结合的MCA对大尺寸荧光猝灭剂的可接近性增加所证明的。在衰竭心肌细胞中,自发性Ca^2+火花(CaSF)的频率远高于正常心肌细胞而DP 2114 -2149的掺入使CaSF显著降低至正常水平(p<0.01);与K201产生的效果相同。我们首先鉴定了K201结合位点为RyR 2的结构域2114 -2149。2750似乎在衰竭的心脏中介导RyR 2的稳定,这可能导致针对心力衰竭和可能致命的心律失常的新的治疗策略。
英文摘要
Two domains within the ryanodine receptor (RyR2) of sarcoplasmic reticulum (SR) {N-terminal (0-600) and central (2000-2500) domains} was found to interact with each other as a regulatory switch for channel gating. We previously reported that K201 (JTV519) inhibits Ca^<2+> leak by correcting the defective inter-domain interaction between the two domains in failing hearts. Here, we identified the K201-binding domain and diaracterizedtherole ofthis novel domain on RyR2 channel gating.An assay using a quartz-crystal microbalance revealed that K201 specifically bound to recornbinant RyR2 fragment: 1741. 2270 in the 1-2750 region. By further analysis of the fragnent1741-2270, 201 was found to specifically bind to its sub-fragment2114-2149. Using the peptide matching this sub-fragment (DP2114-2149)as a carrier, the RyR2 was specifically labeled with methylcoumarin acetate(MCA). Moreover, of several recombinant RyR2 fragments, only fragment 2234-2750 was specifically MCA-labeled; this suggests that the K201 binding domain2114-2149 binds with domain 2234-2750. Addition of DP2114-2149 to the MCA-labeled SR interfered with the interaction between domain2114-2149 and domain2234-2750 causing domain unzipping, as evidenced by an increased accessibility of the bound MCA to a large-size fluorescence quencher. In failing cardiomyocytes, the frequency of spontaneous Ca^<2+> spark (CaSF) was much higher than normal cardiomyocytes (p<0.01), whereas incorporation of DP2114-2149 markedly decreased CaSF to normal level; the same effect as that produced by K201.In conclusion, we first identified the K201-binding site as domain2114-2149 of RyR2 Interruption of the inter-domain interaction between the domain2114-2149 and central domain2234-2750 seems to mediate stabilization of RyR2 in failing hearts, which may lead to a novel therapeutic strategy against heart failure and perhaps lethal arrhythmia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of therapeutic domain within the cardiac ryanodine receptor to correct abnormal Ca2+ release in failing hearts
鉴定心脏兰尼碱受体内的治疗域以纠正衰竭心脏中异常的 Ca2 释放
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Mochizuki, M, Yano, M, Oda, T, Tateishi, H, Kobayashi, S, Yamamoto, T, Ikeda, Y, Ohkusa, T, Ikemoto, N, Matsuzaki, M, Takahiro Tokuhisa, Takahiro Tokuhisa, Masafumi Yano]
通讯作者: Masafumi Yano
Role of ryanodine receptor in heart failure
兰尼碱受体在心力衰竭中的作用
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Mochizuki, M, Yano, M, Oda, T, Tateishi, H, Kobayashi, S, Yamamoto, T, Ikeda, Y, Ohkusa, T, Ikemoto, N, Matsuzaki, M, Takahiro Tokuhisa, Takahiro Tokuhisa, Masafumi Yano, Masafumi Yano, Masafumi Yano]
通讯作者: Masafumi Yano
DOI: 10.1161/circulationaha.107.718957
发表时间: 2008-02-12
期刊: CIRCULATION
影响因子: 37.8
作者: [Yamamoto, Takeshi, Yano, Masafumi, Matsuzaki, Masunori]
通讯作者: Matsuzaki, Masunori
ATI receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress.
ATI受体拮抗剂可恢复心脏兰尼碱受体功能,使异丙肾上腺素引起的衰竭心脏不易受到氧化应激引起的Ca2+泄漏的影响。
DOI: --
发表时间: 2006
期刊: Circulation Journal 70
影响因子: --
作者: [Mochizuki, M, Yano, M, Oda, T, Tateishi, H, Kobayashi, S, Yamamoto, T, Ikeda, Y, Ohkusa, T, Ikemoto, N, Matsuzaki, M, Takahiro Tokuhisa]
通讯作者: Takahiro Tokuhisa
共 8 条
    Comprehensive treatment of heart failure, cardiac hypertrophy, and arrhythmia by controlling ryanodine receptor bound calmodulin
    • 批准号:
      17H04178
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2017
    • 负责人:
      YANO Masafumi
    • 依托单位:
    An attempt to regress cardiac hypertrophy by cardiomyocyte intracellular calmodulin control
    • 批准号:
      16K15443
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2016
    • 负责人:
      YANO Masafumi
    • 依托单位:
    New molecular targeting therapy for regression of cardiac hypertrophy by inhibiting abnormal Ca2+ leak through RyR2 in hypertrophic cardiomyopathy
    • 批准号:
      26670404
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      YANO Masafumi
    • 依托单位:
    Comprehensive strategy of heart failure, cardiac hypertrophy and lethal arrhythmia via stabilizing the stricture of ryanodine receptor
    • 批准号:
      26293189
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      YANO Masafumi
    • 依托单位: